Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD
Open Access
- 24 November 2020
- Vol. 12 (12), 741
- https://doi.org/10.3390/toxins12120741
Abstract
Background: Chronic kidney disease (CKD) is a renal disorder characterized by the accumulation of uremic toxins with limited strategies to reduce their concentrations. A large amount of data supports the pivotal role of intestinal microbiota in CKD complications and as a major source of uremic toxins production. Here, we explored whether fecal microbiota transplantation (FMT) could be attenuated in metabolic complication and uremic toxin accumulation in mice with CKD. Methods: Kidney failure was chemically induced by a diet containing 0.25% (w/w) of adenine for four weeks. Mice were randomized into three groups: control, CKD and CKD + FMT groups. After four weeks, CKD mice underwent fecal microbiota transplantation (FMT) from healthy mice or phosphate buffered saline as control. The gut microbiota structure, uremic toxins plasmatic concentrations, and metabolic profiles were explored three weeks after transplantation. Results: Associated with the increase of alpha diversity, we observed a noticeable improvement of gut microbiota disturbance, after FMT treatment. FMT further decreased p-cresyl sulfate accumulation and improved glucose tolerance. There was no change in kidney function. Conclusions: These data indicate that FMT limited the accumulation of uremic toxins issued from intestinal cresol pathway by a beneficial effect on gut microbiota diversity. Further studies are needed to investigate the FMT efficiency, the timing and feces amount for the transplantation before, to become a therapeutic option in CKD patients.Keywords
This publication has 39 references indexed in Scilit:
- Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative ColitisGastroenterology, 2015
- Antibiotics promote inflammation through the translocation of native commensal colonic bacteriaGut, 2015
- The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl SulfateJournal of the American Society of Nephrology, 2014
- Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cellsNature, 2013
- Chronic kidney disease alters intestinal microbial floraKidney International, 2013
- Fecal Microbiota Transplantation — An Old Therapy Comes of AgeThe New England Journal of Medicine, 2013
- p-Cresyl Sulfate Promotes Insulin Resistance Associated with CKDJournal of the American Society of Nephrology, 2013
- Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injuryAmerican Journal of Physiology-Renal Physiology, 2009
- Assessing the role of p-cresol tolerance in Clostridium difficileJournal of Medical Microbiology, 2008
- Suppressed Serum and Urine Levels of Indoxyl Sulfate by Oral Sorbent in Experimental Uremic RatsAmerican Journal of Nephrology, 1992